BioMarin Pharmaceutical
BMRN
#1453
Rank
$12.18 B
Marketcap
$63.96
Share price
-1.66%
Change (1 day)
-32.25%
Change (1 year)

Earnings for BioMarin Pharmaceutical (BMRN)

Earnings in 2024 (TTM): $0.39 Billion USD

According to BioMarin Pharmaceutical's latest financial reports the company's current earnings are $2.75 Billion USD. In 2023 the company made an earning of $0.18 Billion USD, an increase over its 2022 earnings that were of $0.14 Billion USD. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioMarin Pharmaceutical from 1999 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) $0.39 B107.6%
2023 $0.18 B26.07%
2022 $0.14 B-298.51%
2021 -$75.35 Million78.04%
2020 -$42.33 Million-55.36%
2019 -$94.82 Million-33.56%
2018 -$0.15 Billion297.78%
2017 -$35.88 Million-95.68%
2016 -$0.84 Billion437.12%
2015 -$0.16 Billion23.91%
2014 -$0.13 Billion-29.25%
2013 -$0.18 Billion49.23%
2012 -$0.12 Billion171.11%
2011 -$43.63 Million103.01%
2010 -$21.49 Million-3903.54%
2009 $0.56 M-98.31%
2008 $33.42 M-189.7%
2007 -$37.27 Million51.02%
2006 -$24.68 Million-61.58%
2005 -$64.22 Million-56.59%
2004 -$0.15 Billion95.13%
2003 -$75.81 Million12.09%
2002 -$67.63 Million73.19%
2001 -$39.05 Million18.32%
2000 -$33.01 Million19.65%
1999 -$27.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-$0.5 Billion-226.77%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.14 Billion-134.29%๐Ÿ‡บ๐Ÿ‡ธ USA
-$28.89 Million-107.38%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.40 B 1,792.41%๐Ÿ‡ซ๐Ÿ‡ท France
-$68.35 Million-117.46%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.18 B-51.77%๐Ÿ‡บ๐Ÿ‡ธ USA